Adimab
Vermont, US · Founded 2007 · 137 employees on LinkedIn · 8 known investors
Adimab develops proprietary platforms for antibody and protein therapeutic discovery, engineering fully-functional immunoglobulins in a controllable in vitro eukaryotic system. The company partners with biopharma firms to accelerate the development of transformative protein therapeutics from discovery through clinical progression.
Investors · 8
Founder mafia
2 people who came through Adimab went on to found or lead other companies.
In the news
Frequently asked questions
- What does Adimab do?
- Adimab develops proprietary platforms for antibody and protein therapeutic discovery, engineering fully-functional immunoglobulins in a controllable in vitro eukaryotic system. The company partners with biopharma firms to accelerate the development of transformative protein therapeutics from discovery through clinical progression.
- Who are Adimab's investors?
- Adimab's investors include GrandBanks Capital, LaunchCapital, Lux Capital, Premji Invest, SV Health Investors, Mithril Capital Management, OrbiMed, SV Life Sciences.
- Where is Adimab headquartered?
- Adimab is headquartered in Vermont, US.